1. Home
  2. FUBO vs VIR Comparison

FUBO vs VIR Comparison

Compare FUBO & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo fuboTV Inc.

FUBO

fuboTV Inc.

HOLD

Current Price

$1.34

Market Cap

884.2M

Sector

Industrials

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$7.50

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FUBO
VIR
Founded
N/A
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
884.2M
1.0B
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
FUBO
VIR
Price
$1.34
$7.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
8
Target Price
$3.98
$28.63
AVG Volume (30 Days)
19.1M
1.8M
Earning Date
02-03-2026
02-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,855,678,000.00
$16,860,000.00
Revenue This Year
$10.74
N/A
Revenue Next Year
$10.03
N/A
P/E Ratio
N/A
N/A
Revenue Growth
13.60
N/A
52 Week Low
$1.31
$4.16
52 Week High
$4.72
$10.01

Technical Indicators

Market Signals
Indicator
FUBO
VIR
Relative Strength Index (RSI) 15.09 56.91
Support Level $1.31 $7.08
Resistance Level $1.61 $7.89
Average True Range (ATR) 0.14 0.47
MACD -0.05 -0.03
Stochastic Oscillator 3.54 61.32

Price Performance

Historical Comparison
FUBO
VIR

About FUBO fuboTV Inc.

FuboTV Inc is a sports-first, live TV streaming company offering subscribers access to tens of thousands of live sporting events annually as well as news and entertainment content. Its platform, FuboTV, allows customers to access content through streaming devices and on SmartTVs, mobile phones, tablets, and computers. It offers subscribers a live TV streaming service with the option to purchase incremental features available for purchase that include additional content or enhanced functionality suited to their preferences. The company has one operating segment, the streaming business. Geographically, the company generates a majority of its revenue from the United States and also has a presence in other markets.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: